bioAffinity Technologies (BIAF) Capital Expenditures (2023 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Capital Expenditures of $5663.0 for Q1 2026, down 88.85% year-over-year from $50786.0 in Q1 2025, and up 566200.0% quarter-over-quarter from $1.0 in Q4 2025.
bioAffinity Technologies (BIAF) Capital Expenditures (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Capital Expenditures for 4 consecutive years, with $5663.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 88.85% year-over-year to $5663.0; the TTM figure through Mar 2026 stood at $15445.0 (down 82.54% YoY), while the FY2025 annual figure was $60568.0, down 23.41% from the prior year.
- Capital Expenditures advanced to $5663.0 in Q1 2026 per BIAF's latest filing, from $1.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $50786.0 in Q1 2025 and bottomed at -$13442.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $12939.7 across 4 years, with a median of $5663.0 in 2026.
- Annual changes were most pronounced in 2024 — Capital Expenditures surged 5468.05% — and 2025, when it slumped 138.75%.
- bioAffinity Technologies' Capital Expenditures stood at -$13442.0 in 2023, then surged by 100.01% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025, then soared by 566200.0% to $5663.0 in 2026.
- Business Quant data shows BIAF's Capital Expenditures at $5663.0 in Q1 2026, $1.0 in Q4 2025, and -$3646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 450.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 269.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 76.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 198.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.65 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.79 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 131.60 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 89,970.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89,970.00 |
| Jun 30, 2026 | 89,970.00 |
| Mar 31, 2026 | 5,663.00 |
| Mar 31, 2026 | 5,663.00 |
| Dec 31, 2025 | 1.00 |
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | -3,646.00 |
| Sep 30, 2025 | -3,646.00 |
| Jun 30, 2025 | 13,427.00 |
| Jun 30, 2025 | 13,427.00 |
| Mar 31, 2025 | 50,786.00 |
| Mar 31, 2025 | 50,786.00 |
| Dec 31, 2024 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 9,410.00 |
| Sep 30, 2024 | 9,410.00 |
| Jun 30, 2024 | 28,285.00 |
| Jun 30, 2024 | 28,285.00 |
| Mar 31, 2024 | 41,387.00 |
| Mar 31, 2024 | 41,387.00 |